FDA Adverse Event Injury Summary report: N

GYNECARE TVT-AA ABDOMINAL

MDR report key: 3252531 · Received July 29, 2013

Report

Report Number
2210968-2013-14930
Event Type
Injury
Date Received
July 29, 2013
Report Date
November 10, 2017
Manufacturer
ETHICON INC.
Product Code
OTN
PMA / PMN Number
K012628
Removal / Correction Number
NA
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
TX, US
Reporter Occupation
OTHER

Narratives

Additional Manufacturer Narrative · 1

(B)(4). CONCLUSION: NO CONCLUSION CAN BE DRAWN AT THIS TIME. SHOULD ADDITIONAL INFORMATION BE OBTAINED, A SUPPLEMENTAL 3500A FORM WILL BE SUBMITTED ACCORDINGLY.

Additional Manufacturer Narrative · 1

(B)(4): IT WAS REPORTED THAT THE PATIENT UNDERWENT GYNECOLOGICAL PROCEDURE AND MESH WAS IMPLANTED ALONG WITH CONCURRENT PROCEDURE HYSTERECTOMY. IT WAS REPORTED THAT POST IMPLANTATION, PATIENT EXPERIENCED PAIN, URINARY DISTURBANCES, BLEEDING AND INFECTION.A REVIEW OF THE BATCH MANUFACTURING RECORDS WAS CONDUCTED AND THE BATCH MET ALL FINISHED GOODS RELEASE CRITERIA.

Additional Manufacturer Narrative · 1

(B)(4)

Additional Manufacturer Narrative · 1

(B)(4): IT WAS REPORTED BY AN ATTORNEY THAT THE PATIENT UNDERWENT A GYNECOLOGICAL PROCEDURE ON (B)(6) 2012, AND A MESH WAS IMPLANTED CONCURRENTLY WITH BSO, DUE TO SYMPTOMATIC FIBROID UTERUS, SUI. IT WAS REPORTED THAT PATIENT UNDERWENT EVACUATION OF PELVIC HEMATOMA ON (B)(6) 2012, DUE TO PELVIC HEMATOMA. NO ADDITIONAL INFORMATION WAS PROVIDED.

Description of Event or Problem · 1

IT WAS REPORTED THAT THE PATIENT UNDERWENT A GYNECOLOGICAL PROCEDURE ON (B)(6)2012 AND MESH WAS IMPLANTED INTO THE PATIENT. IT IS REPORTED THAT THE PATIENT EXPERIENCED PAIN, EROSION OF INTERNAL TISSUES, AND HAS UNDERGONE ADDITIONAL SURGERIES AND REVISIONARY PROCEDURES. NO ADDITIONAL INFORMATION IS PROVIDED AT THIS TIME.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
354022 GYNECARE TVT-AA ABDOMINAL MESH, SURGICAL, SYNTHETIC, UROGYNECOLOGIC OTN ETHICON INC. UNK 3537415

Patients

Seq Age Sex Outcome Treatment
1 55 YR Required Intervention